Clinical Trials Logo

Clinical Trial Summary

The BD Veritor™ System is a rapid test that is testing for both COVID-19 and for Influenza This study will try to determine if the BD Veritor™ system can assist in the diagnosis of someone who has upper respiratory infection symptoms. There is both an At-Home self test and test completed by a health care professional that will be completed during this study.


Clinical Trial Description

This is a prospective, multi-country, multicenter, comparative study to assess the performance of the BD Veritor™ At-Home SARS-CoV-2 & Flu A+B test and the BD Veritor™ System for Rapid Detection of SARS-CoV-2 & Flu A+B (Professional use) compared to an FDA approved Flu A/B reference assay (RT-PCR) and FDA authorized molecular SARS-CoV-2 comparator reference method assays. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05352581
Study type Observational
Source Becton, Dickinson and Company
Contact
Status Completed
Phase
Start date July 21, 2022
Completion date April 14, 2023

See also
  Status Clinical Trial Phase
Completed NCT03711292 - Using Behavioral Science to Reduce Inappropriate Antibiotic Use in Acute Care Settings N/A
Completed NCT01168778 - Improving Communication During Pediatric Visits for Acute Respiratory Illness N/A
Terminated NCT00187785 - Doctor-Patient Communication in Spanish N/A
Completed NCT00405509 - The Natural History of Viral Upper Respiratory Infections in Children Aged 6 to Less Than 14 Years N/A
Completed NCT00189475 - Evaluate the Potential of Montelukast to Prevent Nasal Symptomatology During Colds Phase 4
Completed NCT04468204 - Use of Novel Sinusonic Device for Prevention of Community Acquired Upper Respiratory Infection (URI) N/A
Active, not recruiting NCT05666752 - Effect of Intake of Allium Cepa L. Peel Heated Water Extract on Immunity Enhancement N/A
Completed NCT00255307 - Pilot Evaluation of CVT-E002 in Pediatric Upper Respiratory Tract Infection. Phase 2
Suspended NCT05035420 - A Noninvasive Multimodal Biosensing Device for Screening and Monitoring Response to Treatment of Infectious Respiratory Diseases N/A
Recruiting NCT06244615 - Clinical Trial of a Mouth and Throat Rinse for the Treatment of Acute Sore Throat N/A
Completed NCT02694679 - Randomized Controlled Trial of Social Network Targeting in Honduras N/A
Active, not recruiting NCT02943551 - Dialogue Around Respiratory Illness Treatment N/A
Completed NCT02110732 - Lactobacillus Rhamnosus GG in the Middle Ear and Adenoid Tonsil N/A
Completed NCT01657643 - Effect of Probiotics on Health-related Quality of Life in College Students With Upper Respiratory Infections N/A
Completed NCT00694421 - Gas Supply, Demand and Middle Ear Gas Balance: Specific Aim 2 N/A
Completed NCT03884777 - Incidence and Risk of Influenza in Myasthenic Patients
Completed NCT00796315 - Study Evaluating the Pharmacokinetics of Doxylamine Succinate in Children Phase 1
Completed NCT00642681 - Effects of URI on Diabetic Subjects Utilizing Technosphere Insulin After a Meal Challenge Phase 2
Completed NCT00259831 - Efficacy of Cold-FX (CVT-E002) in the Prevention of Upper Respiratory Tract Infections in Healthy Adults Phase 3
Completed NCT04588376 - Improving Antibiotic Prescribing for Pediatric Respiratory Infections by Family Physicians With Peer Comparison N/A